BCIP Life Sciences Associates, LP
Related Filers (25)
- Bain Capital Life Sciences Investors, LLC (23)
- Bain Capital Life Sciences Partners, LP (20)
- Bain Capital Life Sciences Fund, L.P. (18)
- Schwartz Jeffrey Lawrence (16)
- Koppel Adam (15)
- BCLS II Investco (GP), LLC (5)
- Bain Capital Life Sciences Fund II, L.P. (5)
- Bain Capital Life Sciences Investors II, LLC (5)
- BCLS II Investco, LP (5)
- DYNAVAX TECHNOLOGIES CORP (5)
- Dicerna Pharmaceuticals Inc (4)
- Annexon, Inc. (4)
- MARINUS PHARMACEUTICALS INC (2)
- Replimune Group, Inc. (2)
- Arcutis Biotherapeutics, Inc. (2)
- Aptinyx Inc. (2)
- RAPID MICRO BIOSYSTEMS, INC. (2)
- Xilio Therapeutics, Inc. (2)
- BCLS SB Investco, LP (2)
- Solid Biosciences Inc. (2)
- BCLS Fund III Investments GP, LLC (1)
- BCLS Fund III Investments, LP (1)
- Bain Capital Life Sciences Fund III, L.P. (1)
- Bain Capital Life Sciences III General Partner, LLC (1)
- NewAmsterdam Pharma Co N.V. (1)
- Show More ...
Other (9)
144
Tuesday, 10/24/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 10/10/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/8/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 6/14/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 5/18/2023
Filing for proposed sale of securities under Rule 144
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (23)
4
Friday, 1/12/2024
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 12/29/2023
NewAmsterdam Pharma Co N.V.: Initial statement of beneficial ownership of securities
3
Tuesday, 5/30/2023
Annexon, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 5/30/2023
Annexon, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 12/5/2022
Solid Biosciences Inc.: Initial statement of beneficial ownership of securities
4
Friday, 12/10/2021
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/5/2021
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/21/2021
RAPID MICRO BIOSYSTEMS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/14/2021
RAPID MICRO BIOSYSTEMS, INC.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/27/2020
Aptinyx Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/28/2020
Annexon, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Annexon, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 2/6/2020
Arcutis Biotherapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/30/2020
Arcutis Biotherapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 1/16/2020
Aptinyx Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/21/2019
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 5/31/2019
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 7/26/2018
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/19/2018
Replimune Group, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 12/19/2017
MARINUS PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/19/2017
Dicerna Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
3
Thursday, 9/28/2017
MARINUS PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
3
Thursday, 4/13/2017
Dicerna Pharmaceuticals Inc: Initial statement of beneficial ownership of securities